Drug Study Shows No Benefit for Some Covid-19 Patients
By The Wall Street Journal
27/04/20·1m 56s
Regeneron Pharmaceuticals and Sanofi halt a study of arthritis therapy Kevzara for certain Covid-19 patients. Supreme Court rules U.S. must pay insurers. Apple delays iPhone production ramp-up. J.R. Whalen reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices